James M Jenness - Net Worth and Insider Trading

James M Jenness Net Worth

The estimated net worth of James M Jenness is at least $3 Million dollars as of 2024-04-24. James M Jenness is the Director of Kellanova Co and owns about 29,621 shares of Kellanova Co (K) stock worth over $2 Million. James M Jenness is also the Director of Prestige Consumer Healthcare Inc and owns about 11,097 shares of Prestige Consumer Healthcare Inc (PBH) stock worth over $790,328. Details can be seen in James M Jenness's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that James M Jenness has not made any transactions after 2018-02-05 and currently still holds the listed stock(s).

Transaction Summary of James M Jenness

To

James M Jenness Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, James M Jenness owns 3 companies in total, including Prestige Consumer Healthcare Inc (PBH) , Kellanova Co (K) , and Kimberly-Clark Corp (KMB) .

Click here to see the complete history of James M Jenness’s form 4 insider trades.

Insider Ownership Summary of James M Jenness

Ticker Comapny Transaction Date Type of Owner
PBH Prestige Consumer Healthcare Inc 2020-08-04 director
K Kellanova Co 2017-11-09 director
KMB Kimberly-Clark Corp 2007-02-01 director

James M Jenness Latest Holdings Summary

James M Jenness currently owns a total of 2 stocks. Among these stocks, James M Jenness owns 29,621 shares of Kellanova Co (K) as of November 9, 2017, with a value of $2 Million and a weighting of 68.54%. James M Jenness also owns 11,097 shares of Prestige Consumer Healthcare Inc (PBH) as of February 5, 2018, with a value of $790,328 and a weighting of 31.46%.

Latest Holdings of James M Jenness

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
K Kellanova Co 2017-11-09 29,621 58.14 1,722,165
PBH Prestige Consumer Healthcare Inc 2018-02-05 11,097 71.22 790,328

Holding Weightings of James M Jenness


James M Jenness Form 4 Trading Tracker

According to the SEC Form 4 filings, James M Jenness has made a total of 0 transactions in Kellanova Co (K) over the past 5 years. The most-recent trade in Kellanova Co is the sale of 26,592 shares on November 9, 2017, which brought James M Jenness around $2 Million.

According to the SEC Form 4 filings, James M Jenness has made a total of 0 transactions in Prestige Consumer Healthcare Inc (PBH) over the past 5 years. The most-recent trade in Prestige Consumer Healthcare Inc is the acquisition of 4,200 shares on February 5, 2018, which cost James M Jenness around $148,974.

Insider Trading History of James M Jenness

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

James M Jenness Trading Performance

GuruFocus tracks the stock performance after each of James M Jenness's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James M Jenness is -2.52%. GuruFocus also compares James M Jenness's trading performance to market benchmark return within the same time period. The performance of stocks bought by James M Jenness within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how James M Jenness's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of James M Jenness

Average Return

0.39%

Average return per transaction

Outperforming Transactions

67%

2 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 0.3 -2.52 4.51 0.39 9.46 7.89
Relative Return to S&P 500(%) 0.06 -4.65 0.02 -6.25 -3.36 -5.51

James M Jenness Ownership Network

Ownership Network List of James M Jenness

No Data

Ownership Network Relation of James M Jenness


James M Jenness Owned Company Details

What does Prestige Consumer Healthcare Inc do?

Who are the key executives at Prestige Consumer Healthcare Inc?

James M Jenness is the director of Prestige Consumer Healthcare Inc. Other key executives at Prestige Consumer Healthcare Inc include Senior VP Quality & Regulatory Mary Beth Fritz , other: EVP & Marketing & Sales Adel Mekhail , and See Remarks William P'pool .

Prestige Consumer Healthcare Inc (PBH) Insider Trades Summary

Over the past 18 months, James M Jenness made no insider transaction in Prestige Consumer Healthcare Inc (PBH). Other recent insider transactions involving Prestige Consumer Healthcare Inc (PBH) include a net sale of 23,979 shares made by Mary Beth Fritz , a net sale of 54,661 shares made by William P'pool , and a net sale of 49,937 shares made by Adel Mekhail .

In summary, during the past 3 months, insiders sold 77,758 shares of Prestige Consumer Healthcare Inc (PBH) in total and bought 0 shares, with a net sale of 77,758 shares. During the past 18 months, 285,483 shares of Prestige Consumer Healthcare Inc (PBH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 285,483 shares.

Prestige Consumer Healthcare Inc (PBH)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Prestige Consumer Healthcare Inc Insider Transactions

No Available Data

James M Jenness Mailing Address

Above is the net worth, insider trading, and ownership report for James M Jenness. You might contact James M Jenness via mailing address: Po Box 3599, Battlecreek Mi 49016-3599.

Discussions on James M Jenness

No discussions yet.